APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Major Depressive Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Major Depressive Disorder Drug Industry Growth and Trends Forecast to 2032

Report ID 174009940126 December 202593 pages

Choose your research edition.

Industry ResearchMajor Depressive Disorder Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Major Depressive Disorder Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Major Depressive Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Major Depressive Disorder Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Major Depressive Disorder Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Major Depressive Disorder Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Major Depressive Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Major Depressive Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Major Depressive Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Major Depressive Disorder Drug include Eli Lilly and Company, GlaxoSmithKline Plc, Intra-Cellular Therapies, Inc., Hua Medicine Ltd., H. Lundbeck A/S, F. Hoffmann-La Roche Ltd., e-Therapeutics Plc, Cerecor Inc. and Bristol-Myers Squibb Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Major Depressive Disorder Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Major Depressive Disorder Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Major Depressive Disorder Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Major Depressive Disorder Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Major Depressive Disorder Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Major Depressive Disorder Drug Market by Company

Eli Lilly and Company

GlaxoSmithKline Plc

Intra-Cellular Therapies, Inc.

Hua Medicine Ltd.

H. Lundbeck A/S

F. Hoffmann-La Roche Ltd.

e-Therapeutics Plc

Cerecor Inc.

Bristol-Myers Squibb Company

Major Depressive Disorder Drug Segment by Type

AV-101

AVP-786

Basimglurant

Aripiprazole

Brexpiprazole

Others

Major Depressive Disorder Drug Segment by Application

Research Center

Hospital

Clinic

Major Depressive Disorder Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Major Depressive Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Major Depressive Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Major Depressive Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Major Depressive Disorder Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Major Depressive Disorder Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AV-101 Table 2. Major Company of AVP-786 Table 3. Major Company of Basimglurant Table 4. Major Company of Aripiprazole Table 5. Major Company of Brexpiprazole Table 6. Major Company of Others Table 7. Global Major Depressive Disorder Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Major Depressive Disorder Drug Sales by Type (2021-2026) & (W Units) Table 9. Global Major Depressive Disorder Drug Sales Market Share in Volume by Type (2021-2026) Table 10. Global Major Depressive Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 11. Global Major Depressive Disorder Drug Sales Market Share in Value by Type (2021-2026) Table 12. Global Major Depressive Disorder Drug Price by Type (2021-2026) & (US$/Unit) Table 13. Global Major Depressive Disorder Drug Sales by Type (2027-2032) & (W Units) Table 14. Global Major Depressive Disorder Drug Sales Market Share in Volume by Type (2027-2032) Table 15. Global Major Depressive Disorder Drug Sales by Type (2027-2032) & (US$ Million) Table 16. Global Major Depressive Disorder Drug Sales Market Share in Value by Type (2027-2032) Table 17. Global Major Depressive Disorder Drug Price by Type (2027-2032) & (US$/Unit) Table 18. North America Major Depressive Disorder Drug Sales by Type (2021-2026) & (W Units) Table 19. North America Major Depressive Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Major Depressive Disorder Drug Sales by Type (2021-2026) & (W Units) Table 21. Europe Major Depressive Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Major Depressive Disorder Drug Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Major Depressive Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Major Depressive Disorder Drug Sales by Type (2021-2026) & (W Units) Table 25. Latin America Major Depressive Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Major Depressive Disorder Drug Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Major Depressive Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 28. Major Depressive Disorder Drug Industry Trends Table 29. Major Depressive Disorder Drug Industry Drivers Table 30. Major Depressive Disorder Drug Industry Opportunities and Challenges Table 31. Major Depressive Disorder Drug Industry Restraints Table 32. Global Major Depressive Disorder Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Major Depressive Disorder Drug Revenue Market Share by Company (2021-2026) Table 34. Global Major Depressive Disorder Drug Sales by Company (2021-2026) & (W Units) Table 35. Global Major Depressive Disorder Drug Sales Share by Company (2021-2026) Table 36. Global Major Depressive Disorder Drug Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Major Depressive Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Major Depressive Disorder Drug Major Company Production Sites and Headquarters Table 39. Global Major Depressive Disorder Drug Company, Product Type & Application Table 40. Global Major Depressive Disorder Drug Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Major Depressive Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Major Depressive Disorder Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Major Depressive Disorder Drug Sales by Region (2021-2026) & (W Units) Table 45. Global Major Depressive Disorder Drug Sales Market Share in Volume by Region (2021-2026) Table 46. Global Major Depressive Disorder Drug Sales by Region (2021-2026) & (US$ Million) Table 47. Global Major Depressive Disorder Drug Sales Market Share in Value by Region (2021-2026) Table 48. Global Major Depressive Disorder Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Major Depressive Disorder Drug Sales by Region (2027-2032) & (W Units) Table 50. Global Major Depressive Disorder Drug Sales Market Share in Volume by Region (2027-2032) Table 51. Global Major Depressive Disorder Drug Sales by Region (2027-2032) & (US$ Million) Table 52. Global Major Depressive Disorder Drug Sales Market Share in Value by Region (2027-2032) Table 53. Global Major Depressive Disorder Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Major Depressive Disorder Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Major Depressive Disorder Drug Sales by Application (2021-2026) & (W Units) Table 56. Global Major Depressive Disorder Drug Sales Market Share in Volume by Application (2021-2026) Table 57. Global Major Depressive Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 58. Global Major Depressive Disorder Drug Sales Market Share in Value by Application (2021-2026) Table 59. Global Major Depressive Disorder Drug Price by Application (2021-2026) & (US$/Unit) Table 60. Global Major Depressive Disorder Drug Sales by Application (2027-2032) & (W Units) Table 61. Global Major Depressive Disorder Drug Sales Market Share in Volume by Application (2027-2032) Table 62. Global Major Depressive Disorder Drug Sales by Application (2027-2032) & (US$ Million) Table 63. Global Major Depressive Disorder Drug Sales Market Share in Value by Application (2027-2032) Table 64. Global Major Depressive Disorder Drug Price by Application (2027-2032) & (US$/Unit) Table 65. North America Major Depressive Disorder Drug Sales by Application (2021-2026) & (W Units) Table 66. North America Major Depressive Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Major Depressive Disorder Drug Sales by Application (2021-2026) & (W Units) Table 68. Europe Major Depressive Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Major Depressive Disorder Drug Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Major Depressive Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Major Depressive Disorder Drug Sales by Application (2021-2026) & (W Units) Table 72. Latin America Major Depressive Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Major Depressive Disorder Drug Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Major Depressive Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 75. Eli Lilly and Company Company Information Table 76. Eli Lilly and Company Business Overview Table 77. Eli Lilly and Company Major Depressive Disorder Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Eli Lilly and Company Major Depressive Disorder Drug Product Portfolio Table 79. Eli Lilly and Company Recent Development Table 80. GlaxoSmithKline Plc Company Information Table 81. GlaxoSmithKline Plc Business Overview Table 82. GlaxoSmithKline Plc Major Depressive Disorder Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GlaxoSmithKline Plc Major Depressive Disorder Drug Product Portfolio Table 84. GlaxoSmithKline Plc Recent Development Table 85. Intra-Cellular Therapies, Inc. Company Information Table 86. Intra-Cellular Therapies, Inc. Business Overview Table 87. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product Portfolio Table 89. Intra-Cellular Therapies, Inc. Recent Development Table 90. Hua Medicine Ltd. Company Information Table 91. Hua Medicine Ltd. Business Overview Table 92. Hua Medicine Ltd. Major Depressive Disorder Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Hua Medicine Ltd. Major Depressive Disorder Drug Product Portfolio Table 94. Hua Medicine Ltd. Recent Development Table 95. H. Lundbeck A/S Company Information Table 96. H. Lundbeck A/S Business Overview Table 97. H. Lundbeck A/S Major Depressive Disorder Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. H. Lundbeck A/S Major Depressive Disorder Drug Product Portfolio Table 99. H. Lundbeck A/S Recent Development Table 100. F. Hoffmann-La Roche Ltd. Company Information Table 101. F. Hoffmann-La Roche Ltd. Business Overview Table 102. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Portfolio Table 104. F. Hoffmann-La Roche Ltd. Recent Development Table 105. e-Therapeutics Plc Company Information Table 106. e-Therapeutics Plc Business Overview Table 107. e-Therapeutics Plc Major Depressive Disorder Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. e-Therapeutics Plc Major Depressive Disorder Drug Product Portfolio Table 109. e-Therapeutics Plc Recent Development Table 110. Cerecor Inc. Company Information Table 111. Cerecor Inc. Business Overview Table 112. Cerecor Inc. Major Depressive Disorder Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Cerecor Inc. Major Depressive Disorder Drug Product Portfolio Table 114. Cerecor Inc. Recent Development Table 115. Bristol-Myers Squibb Company Company Information Table 116. Bristol-Myers Squibb Company Business Overview Table 117. Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Portfolio Table 119. Bristol-Myers Squibb Company Recent Development Table 120. North America Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 121. North America Major Depressive Disorder Drug Sales by Country (2021-2026) & (W Units) Table 122. North America Major Depressive Disorder Drug Sales Market Share by Country (2021-2026) Table 123. North America Major Depressive Disorder Drug Sales Forecast by Country (2027-2032) & (W Units) Table 124. North America Major Depressive Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 125. North America Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. North America Major Depressive Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 127. North America Major Depressive Disorder Drug Market Share by Country (2021-2026) Table 128. North America Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. North America Major Depressive Disorder Drug Market Share Forecast by Country (2027-2032) Table 130. Europe Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 131. Europe Major Depressive Disorder Drug Sales by Country (2021-2026) & (W Units) Table 132. Europe Major Depressive Disorder Drug Sales Market Share by Country (2021-2026) Table 133. Europe Major Depressive Disorder Drug Sales Forecast by Country (2027-2032) & (W Units) Table 134. Europe Major Depressive Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 135. Europe Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Europe Major Depressive Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 137. Europe Major Depressive Disorder Drug Market Share by Country (2021-2026) Table 138. Europe Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Europe Major Depressive Disorder Drug Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Major Depressive Disorder Drug Sales by Country (2021-2026) & (W Units) Table 142. Asia-Pacific Major Depressive Disorder Drug Sales Market Share by Country (2021-2026) Table 143. Asia-Pacific Major Depressive Disorder Drug Sales Forecast by Country (2027-2032) & (W Units) Table 144. Asia-Pacific Major Depressive Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Major Depressive Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 147. Asia-Pacific Major Depressive Disorder Drug Market Share by Country (2021-2026) Table 148. Asia-Pacific Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Asia-Pacific Major Depressive Disorder Drug Market Share Forecast by Country (2027-2032) Table 150. Latin America Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 151. Latin America Major Depressive Disorder Drug Sales by Country (2021-2026) & (W Units) Table 152. Latin America Major Depressive Disorder Drug Sales Market Share by Country (2021-2026) Table 153. Latin America Major Depressive Disorder Drug Sales Forecast by Country (2027-2032) & (W Units) Table 154. Latin America Major Depressive Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 155. Latin America Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Latin America Major Depressive Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 157. Latin America Major Depressive Disorder Drug Market Share by Country (2021-2026) Table 158. Latin America Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Latin America Major Depressive Disorder Drug Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Major Depressive Disorder Drug Sales by Country (2021-2026) & (W Units) Table 162. Middle East and Africa Major Depressive Disorder Drug Sales Market Share by Country (2021-2026) Table 163. Middle East and Africa Major Depressive Disorder Drug Sales Forecast by Country (2027-2032) & (W Units) Table 164. Middle East and Africa Major Depressive Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Major Depressive Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 167. Middle East and Africa Major Depressive Disorder Drug Market Share by Country (2021-2026) Table 168. Middle East and Africa Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Middle East and Africa Major Depressive Disorder Drug Market Share Forecast by Country (2027-2032) Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Major Depressive Disorder Drug Distributors List Table 173. Major Depressive Disorder Drug Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Major Depressive Disorder Drug Image Figure 2. Global Major Depressive Disorder Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Major Depressive Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Major Depressive Disorder Drug Sales (2021-2032) & (W Units) Figure 5. AV-101 Image Figure 6. Global AV-101 Sales YoY Growth (2021-2032) & (W Units) Figure 7. AVP-786 Image Figure 8. Global AVP-786 Sales YoY Growth (2021-2032) & (W Units) Figure 9. Basimglurant Image Figure 10. Global Basimglurant Sales YoY Growth (2021-2032) & (W Units) Figure 11. Aripiprazole Image Figure 12. Global Aripiprazole Sales YoY Growth (2021-2032) & (W Units) Figure 13. Brexpiprazole Image Figure 14. Global Brexpiprazole Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Major Depressive Disorder Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Major Depressive Disorder Drug Market Share by Type 2025 VS 2032 Figure 19. North America Major Depressive Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 20. North America Major Depressive Disorder Drug Sales Market Share in Value by Type in 2025 Figure 21. Europe Major Depressive Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 22. Europe Major Depressive Disorder Drug Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Major Depressive Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Major Depressive Disorder Drug Sales Market Share in Value by Type in 2025 Figure 25. Latin America Major Depressive Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Major Depressive Disorder Drug Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Major Depressive Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Major Depressive Disorder Drug Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Major Depressive Disorder Drug Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Research Center Image Figure 32. Global Research Center Sales YoY Growth (2021-2032) & (W Units) Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 35. Clinic Image Figure 36. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 37. Global Major Depressive Disorder Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Major Depressive Disorder Drug Market Share by Application 2025 VS 2032 Figure 39. North America Major Depressive Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Major Depressive Disorder Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Major Depressive Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Major Depressive Disorder Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Major Depressive Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Major Depressive Disorder Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Major Depressive Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Major Depressive Disorder Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Major Depressive Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Major Depressive Disorder Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Major Depressive Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. North America Major Depressive Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Major Depressive Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Major Depressive Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Major Depressive Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Europe Major Depressive Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Major Depressive Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Major Depressive Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Major Depressive Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Asia-Pacific Major Depressive Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Major Depressive Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Major Depressive Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Major Depressive Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Latin America Major Depressive Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Major Depressive Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Major Depressive Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Major Depressive Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Middle East and Africa Major Depressive Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Major Depressive Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Major Depressive Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Major Depressive Disorder Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Major Depressive Disorder Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • AV-101
  • AVP-786
  • Basimglurant
  • Aripiprazole
  • Brexpiprazole
  • Others
Applications
  • Research Center
  • Hospital
  • Clinic
Companies covered
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Intra-Cellular Therapies, Inc.
  • Hua Medicine Ltd.
  • H. Lundbeck A/S
  • F. Hoffmann-La Roche Ltd.
  • e-Therapeutics Plc
  • Cerecor Inc.
  • Bristol-Myers Squibb Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Major Depressive Disorder Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Major Depressive Disorder Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Major Depressive Disorder Drug Market by Type
  6. 1.3.1 AV-101
  7. 1.3.2 AVP-786
  8. 1.3.3 Basimglurant
  9. 1.3.4 Aripiprazole
  10. 1.3.5 Brexpiprazole
  11. 1.3.6 Others
  12. 1.4 Global Major Depressive Disorder Drug Market Size by Type
  13. 1.4.1 Global Major Depressive Disorder Drug Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Major Depressive Disorder Drug Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Major Depressive Disorder Drug Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Major Depressive Disorder Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Major Depressive Disorder Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Major Depressive Disorder Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Major Depressive Disorder Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Major Depressive Disorder Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Major Depressive Disorder Drug Industry Trends
  2. 2.2 Major Depressive Disorder Drug Industry Drivers
  3. 2.3 Major Depressive Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Major Depressive Disorder Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Major Depressive Disorder Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Major Depressive Disorder Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Major Depressive Disorder Drug Price (2021-2026)
  4. 3.4 Global Major Depressive Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Major Depressive Disorder Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Major Depressive Disorder Drug Company, Product Type & Application
  7. 3.7 Global Major Depressive Disorder Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Major Depressive Disorder Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Major Depressive Disorder Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Major Depressive Disorder Drug Tier 1, Tier 2, and Tier 3
4 Major Depressive Disorder Drug Regional Status and Outlook
  1. 4.1 Global Major Depressive Disorder Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Major Depressive Disorder Drug Historic Market Size by Region
  3. 4.2.1 Global Major Depressive Disorder Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Major Depressive Disorder Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Major Depressive Disorder Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Major Depressive Disorder Drug Forecasted Market Size by Region
  7. 4.3.1 Global Major Depressive Disorder Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Major Depressive Disorder Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Major Depressive Disorder Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Major Depressive Disorder Drug by Application
  1. 5.1 Major Depressive Disorder Drug Market by Application
  2. 5.1.1 Research Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Major Depressive Disorder Drug Market Size by Application
  6. 5.2.1 Global Major Depressive Disorder Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Major Depressive Disorder Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Major Depressive Disorder Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Major Depressive Disorder Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Major Depressive Disorder Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Major Depressive Disorder Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Major Depressive Disorder Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Major Depressive Disorder Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly and Company
  2. 6.1.1 Eli Lilly and Company Company Information
  3. 6.1.2 Eli Lilly and Company Business Overview
  4. 6.1.3 Eli Lilly and Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly and Company Major Depressive Disorder Drug Product Portfolio
  6. 6.1.5 Eli Lilly and Company Recent Developments
  7. 6.2 GlaxoSmithKline Plc
  8. 6.2.1 GlaxoSmithKline Plc Company Information
  9. 6.2.2 GlaxoSmithKline Plc Business Overview
  10. 6.2.3 GlaxoSmithKline Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Plc Major Depressive Disorder Drug Product Portfolio
  12. 6.2.5 GlaxoSmithKline Plc Recent Developments
  13. 6.3 Intra-Cellular Therapies, Inc.
  14. 6.3.1 Intra-Cellular Therapies, Inc. Company Information
  15. 6.3.2 Intra-Cellular Therapies, Inc. Business Overview
  16. 6.3.3 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product Portfolio
  18. 6.3.5 Intra-Cellular Therapies, Inc. Recent Developments
  19. 6.4 Hua Medicine Ltd.
  20. 6.4.1 Hua Medicine Ltd. Company Information
  21. 6.4.2 Hua Medicine Ltd. Business Overview
  22. 6.4.3 Hua Medicine Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hua Medicine Ltd. Major Depressive Disorder Drug Product Portfolio
  24. 6.4.5 Hua Medicine Ltd. Recent Developments
  25. 6.5 H. Lundbeck A/S
  26. 6.5.1 H. Lundbeck A/S Company Information
  27. 6.5.2 H. Lundbeck A/S Business Overview
  28. 6.5.3 H. Lundbeck A/S Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 H. Lundbeck A/S Major Depressive Disorder Drug Product Portfolio
  30. 6.5.5 H. Lundbeck A/S Recent Developments
  31. 6.6 F. Hoffmann-La Roche Ltd.
  32. 6.6.1 F. Hoffmann-La Roche Ltd. Company Information
  33. 6.6.2 F. Hoffmann-La Roche Ltd. Business Overview
  34. 6.6.3 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Portfolio
  36. 6.6.5 F. Hoffmann-La Roche Ltd. Recent Developments
  37. 6.7 e-Therapeutics Plc
  38. 6.7.1 e-Therapeutics Plc Company Information
  39. 6.7.2 e-Therapeutics Plc Business Overview
  40. 6.7.3 e-Therapeutics Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 e-Therapeutics Plc Major Depressive Disorder Drug Product Portfolio
  42. 6.7.5 e-Therapeutics Plc Recent Developments
  43. 6.8 Cerecor Inc.
  44. 6.8.1 Cerecor Inc. Company Information
  45. 6.8.2 Cerecor Inc. Business Overview
  46. 6.8.3 Cerecor Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cerecor Inc. Major Depressive Disorder Drug Product Portfolio
  48. 6.8.5 Cerecor Inc. Recent Developments
  49. 6.9 Bristol-Myers Squibb Company
  50. 6.9.1 Bristol-Myers Squibb Company Company Information
  51. 6.9.2 Bristol-Myers Squibb Company Business Overview
  52. 6.9.3 Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Portfolio
  54. 6.9.5 Bristol-Myers Squibb Company Recent Developments
7 North America by Country
  1. 7.1 North America Major Depressive Disorder Drug Sales by Country
  2. 7.1.1 North America Major Depressive Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Major Depressive Disorder Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Major Depressive Disorder Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Major Depressive Disorder Drug Market Size by Country
  6. 7.2.1 North America Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Major Depressive Disorder Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Major Depressive Disorder Drug Sales by Country
  2. 8.1.1 Europe Major Depressive Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Major Depressive Disorder Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Major Depressive Disorder Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Major Depressive Disorder Drug Market Size by Country
  6. 8.2.1 Europe Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Major Depressive Disorder Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Major Depressive Disorder Drug Sales by Country
  2. 9.1.1 Asia-Pacific Major Depressive Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Major Depressive Disorder Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Major Depressive Disorder Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Major Depressive Disorder Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Major Depressive Disorder Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Major Depressive Disorder Drug Sales by Country
  2. 10.1.1 South America Major Depressive Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Major Depressive Disorder Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Major Depressive Disorder Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Major Depressive Disorder Drug Market Size by Country
  6. 10.2.1 South America Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Major Depressive Disorder Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Major Depressive Disorder Drug Sales by Country
  2. 11.1.1 Middle East and Africa Major Depressive Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Major Depressive Disorder Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Major Depressive Disorder Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Major Depressive Disorder Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Major Depressive Disorder Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Major Depressive Disorder Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Major Depressive Disorder Drug Value Chain Analysis
  2. 12.1.1 Major Depressive Disorder Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Major Depressive Disorder Drug Production Mode & Process
  7. 12.2 Major Depressive Disorder Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Major Depressive Disorder Drug Distributors
  10. 12.2.3 Major Depressive Disorder Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst